Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

Mature Follow up from a Phase 2 Study of PI3K-Delta Inhibitor Idelalisib in Patients with Double (Rituximab and Alkylating agent)-Refractory Indolent B-Cell Non-Hodgkin Lymphoma (iNHL)

Ajay K. Gopal, MD, Brad S. Kahl, MD, Sven de Vos, MD PhD, Nina D. Wagner-Johnston, MD, Stephen J. Schuster, MD, Wojciech Jurczak, MD PhD, Ian W. Flinn, MD PhD, Christopher R. Flowers, MD, Peter Martin, MD, Andreas Viardot, MD, Kristie A. Blum, MD, Andre Goy, MD, Andrew Davies, BM PhD, Pier Luigi Zinzani, MD, Martin H. Dreyling, MD, Leanne M. Holes, Bess Sorensen, PhD, Wayne R. Godfrey, MD, Gilles Andre Salles, MD PhD

Blood (2014) 124 (21): 1708.

https://doi.org/10.1182/blood.V124.21.1708.1708

Published: 2014